US Pre-Market SEC Filings Roundup — July 07, 2026

06-07-2026

VP Comm. Sales & Marketing Nagai Yoshio was awarded 159,982 Ordinary Shares. Nagai Yoshio holds 8,095,472 shares after the transaction.

• · VP Comm. Sales & Marketing Nagai Yoshio was awarded 159,982 Ordinary Shares

06-07-2026

Director TULLOCH MAURICE was awarded 406 Common Stock at $215.65 (~$87.6K). TULLOCH MAURICE holds 406 shares after the transaction.

• · Director TULLOCH MAURICE was awarded 406 Common Stock at $215.65 (~$87.6K)

06-07-2026

Chief Executive Officer Willard Stephen H had withheld for taxes 18,046 Class A Common Stock at $0.73 (~$13.2K). Willard Stephen H holds 771,681 shares after the transaction.

• · Chief Executive Officer Willard Stephen H had withheld for taxes 18,046 Class A Common Stock at $0.73 (~$13.2K)

06-07-2026

Executive VP, GC, CCO and Secy Johnston James David sold 2,600 Common Stock at $29.72 (~$77.3K). Johnston James David holds 75,357 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Executive VP, GC, CCO and Secy Johnston James David sold 2,600 Common Stock at $29.72 (~$77.3K)

06-07-2026

SEC. AND CHIEF LEGAL OFFICER RABINOWITZ DANIEL sold 3,705 Common Stock at $268.11 (~$993K). 12 transactions reported in total. RABINOWITZ DANIEL holds 172,294 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · SEC. AND CHIEF LEGAL OFFICER RABINOWITZ DANIEL sold 1,568 Common Stock at $266.79 (~$418K)
• · SEC. AND CHIEF LEGAL OFFICER RABINOWITZ DANIEL sold 3,705 Common Stock at $268.11 (~$993K)
• · SEC. AND CHIEF LEGAL OFFICER RABINOWITZ DANIEL sold 1,932 Common Stock at $268.99 (~$520K)
• · SEC. AND CHIEF LEGAL OFFICER RABINOWITZ DANIEL sold 484 Common Stock at $269.87 (~$131K)
• · SEC. AND CHIEF LEGAL OFFICER RABINOWITZ DANIEL sold 1,357 Common Stock at $270.96 (~$368K)
• · SEC. AND CHIEF LEGAL OFFICER RABINOWITZ DANIEL sold 454 Common Stock at $272.14 (~$124K)
• · SEC. AND CHIEF LEGAL OFFICER RABINOWITZ DANIEL sold 500 Common Stock at $274.19 (~$137K)
• · SEC. AND CHIEF LEGAL OFFICER RABINOWITZ DANIEL sold 1,100 Common Stock at $275.20 (~$303K)

06-07-2026

Director BINZ JOSEPH LEO was awarded 3,924 Common Stock. BINZ JOSEPH LEO holds 3,924 shares after the transaction.

• · Director BINZ JOSEPH LEO was awarded 3,924 Common Stock

06-07-2026

See Remarks Wang David H was awarded 6,208 Restricted Stock Units.

• · See Remarks Wang David H was awarded 6,208 Restricted Stock Units

06-07-2026

Chief Financial Officer Parekh Sonalee Elizabeth sold 33,823 Class A Common Stock at $17.89 (~$605K). Parekh Sonalee Elizabeth holds 977,268 shares after the transaction.

• · Chief Financial Officer Parekh Sonalee Elizabeth sold 33,823 Class A Common Stock at $17.89 (~$605K)

06-07-2026

See Remarks Frangou Angeliki bought 1,173 Common Unit at $73.05 (~$85.7K). Frangou Angeliki holds 4,762,129 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · See Remarks Frangou Angeliki bought 1,189 Common Unit at $71.59 (~$85.1K)
• · See Remarks Frangou Angeliki bought 1,173 Common Unit at $73.05 (~$85.7K)
• · See Remarks Frangou Angeliki bought 1,149 Common Unit at $74.48 (~$85.6K)

06-07-2026

Regal Partners Funds Management Pty Ltd and Regal Partners Ltd disclosed a 11.62% beneficial ownership stake in EBR Systems, Inc., holding 87,510,124 ordinary shares as of June 30, 2026. The filing is an amendment to Schedule 13G, indicating the shares were acquired in the ordinary course of business and not for control purposes.

• · The filing is an amendment (SC 13G/A) filed on July 6, 2026, with an event date of June 30, 2026.
• · Regal Partners Funds Management Pty Ltd and Regal Partners Ltd are both based in Sydney, Australia.
• · The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

06-07-2026

Yi Wu and his entity Rosy Time Global Limited filed an amended Schedule 13D disclosing a reduction in beneficial ownership of LexinFintech Holdings Ltd. due to open-market sales of ADSs. As of July 2, 2026, Yi Wu beneficially owns 20,196,118 Class A ordinary shares (6.1% of total outstanding shares), while Rosy Time Global holds 19,123,466 shares (5.8%). The filing notes that Mr. Wu has been selling ADSs in the open market over the past 60 days, indicating a continued reduction in his stake.

• · Total outstanding ordinary shares as of Feb 28, 2026: 329,576,547 (258,234,320 Class A + 71,342,227 Class B).
• · The reduction in ownership resulted from open-market sales of ADSs by Yi Wu, including a sale on July 1, 2026.
• · No other contracts, arrangements, or understandings regarding the issuer's securities were disclosed.

06-07-2026

Director ALBA MANUEL sold 30,141 Common Stock at $430.79 (~$13M). 29 transactions reported in total. ALBA MANUEL holds 1,287,524 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Director ALBA MANUEL sold 5,837 Common Stock at $429.58 (~$2.51M)
• · Director ALBA MANUEL sold 30,141 Common Stock at $430.79 (~$13M)
• · Director ALBA MANUEL sold 3,485 Common Stock at $432.79 (~$1.51M)
• · Director ALBA MANUEL sold 1,574 Common Stock at $433.43 (~$682K)
• · Director ALBA MANUEL sold 2,279 Common Stock at $434.78 (~$991K)
• · Director ALBA MANUEL sold 2,122 Common Stock at $435.76 (~$925K)
• · Director ALBA MANUEL sold 3,655 Common Stock at $436.82 (~$1.6M)
• · Director ALBA MANUEL sold 2,129 Common Stock at $437.93 (~$932K)

06-07-2026

Chief Operating Officer Rosa Luvizotto Glauber sold 19,010 Common Shares at $65.23 (~$1.24M). Rosa Luvizotto Glauber holds 390,628 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Chief Operating Officer Rosa Luvizotto Glauber sold 19,010 Common Shares at $65.23 (~$1.24M)

06-07-2026

Sofinnova Crossover I SLP and affiliated entities filed Amendment No. 6 to their Schedule 13D, disclosing a series of open-market sales of Abivax S.A. ordinary shares and ADSs between June 30 and July 6, 2026. Following these transactions, Sofinnova Crossover I SLP directly holds 2,474,299 ordinary shares (3.1% of outstanding shares) and 3,535,843 voting rights (4.3% of outstanding voting rights), down from a prior position. The sales reflect a reduction in the reporting group's stake, though they retain the ability to acquire or dispose of shares in the future.

• · Sales occurred between June 30 and July 6, 2026, on NASDAQ and Euronext.
• · On June 30, 2026: sold 500,000 ADSs at weighted average price of $132.7347 per share.
• · On July 1, 2026: sold 25,000 ADSs at weighted average price of $134.2377 per share.
• · On July 2, 2026: sold 275,000 ADSs at $140.9365 and 35,469 ordinary shares at $144.2752 per share.
• · On July 3, 2026: sold 25,000 ordinary shares at $156.2041 and 39,531 ordinary shares at $155.0654 per share.
• · On July 6, 2026: sold 3,195 ordinary shares at $155.0436 per share.
• · Euro-denominated transactions were converted to USD at an exchange rate of $1.1448 as of July 3, 2026.
• · The reporting group's beneficial ownership is based on 79,782,941 ordinary shares outstanding (May 31, 2026).
• · Voting percentage is based on 82,130,598 voting rights outstanding (May 31, 2026).
• · No other reportable transactions occurred within the last 60 days by the Reporting Persons.

06-07-2026

Chief Technology Officer Dickman Thomas J sold 5 Common Stock at $0.49 (~$2.46). Dickman Thomas J holds 539,579 shares after the transaction.

• · Chief Technology Officer Dickman Thomas J exercised/converted 17 Common Stock
• · Chief Technology Officer Dickman Thomas J sold 5 Common Stock at $0.49 (~$2.46)
• · Chief Technology Officer Dickman Thomas J exercised/converted 17 Restricted Stock Units

06-07-2026

Director KEITH DANIEL C sold 17,000 Class A Common Stock at $15.02 (~$255K). KEITH DANIEL C holds 25,122 shares after the transaction.

• · Director KEITH DANIEL C sold 17,000 Class A Common Stock at $15.02 (~$255K)

06-07-2026

SVP & CFO CAREY STEPHEN P. sold 3,313 Common Stock at $86.00 (~$285K). CAREY STEPHEN P. holds 177,543 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · SVP & CFO CAREY STEPHEN P. exercised/converted 3,313 Common Stock at $49.51 (~$164K)
• · SVP & CFO CAREY STEPHEN P. sold 3,313 Common Stock at $86.00 (~$285K)
• · SVP & CFO CAREY STEPHEN P. exercised/converted 3,313 Stock Option (right to buy) at $49.51 (~$164K)

06-07-2026

Chief Commercial Officer Wheeler Ashlee had withheld for taxes 605 Common Stock at $1.74 (~$1.05K). Wheeler Ashlee holds 206,251 shares after the transaction.

• · Chief Commercial Officer Wheeler Ashlee had withheld for taxes 605 Common Stock at $1.74 (~$1.05K)

06-07-2026

Director Cerberus Capital Management, L.P. was awarded 16,461 Common Stock. Cerberus Capital Management, L.P. holds 3,417,940 shares after the transaction.

• · Director Cerberus Capital Management, L.P. was awarded 16,461 Common Stock

06-07-2026

Paul R. Ried Financial Group, LLC filed a Schedule 13G with the SEC on July 6, 2026, disclosing beneficial ownership of 1,138,859 shares of MFS Active Exchange Traded Funds Trust, representing 6.2% of the outstanding shares. The filing indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · The filing is made pursuant to Rule 13d-1(b), indicating the filer is an institutional investment manager.
• · Paul R. Ried Financial Group, LLC has sole voting power and sole dispositive power over all 1,138,859 shares.
• · The filer's business address is 10801 Main Street, Suite 201, Bellevue, WA 98004.
• · The filing date is July 6, 2026, with the date as of change also July 6, 2026.

07-07-2026

Getty Images Holdings, Inc. terminated its merger agreement with Shutterstock, Inc. on July 7, 2026, after the Board unanimously decided not to proceed with a required CMA-mandated sale of Shutterstock's editorial business and allowed the Second Extended End Date to pass on July 6, 2026. Following termination, Getty Images will redeem its outstanding 10.500% senior secured notes due 2030. The filing does not disclose any financial performance metrics, so no period-over-period comparisons are available.

• · The merger agreement was originally entered into on January 6, 2025.
• · The Board of Directors unanimously resolved on June 30, 2026, not to proceed with the sale of Shutterstock's editorial business under CMA supervision.
• · The Second Extended End Date under the Merger Agreement was July 6, 2026.
• · Termination notice was delivered to Shutterstock on July 7, 2026, effective upon delivery.
• · Getty Images' 10.500% senior secured notes due 2030 will be redeemed following termination.

07-07-2026

China Yuchai International Limited filed a 6-K with the SEC on July 7, 2026, announcing its notice of Annual General Meeting (AGM). The filing includes a press release and a proxy card. No financial results or material business updates were provided.

• · Filing type: 6-K
• · Exhibits include press release (99.1) and proxy card (99.2)
• · Commission file number: 1-13522

07-07-2026

Tower Semiconductor announced it will release its second quarter 2026 earnings on August 4, 2026, and hold a conference call the same day to discuss results and third quarter guidance. The filing provides no actual financial data, only the schedule for the upcoming earnings announcement.

• · Earnings release and conference call scheduled for August 4, 2026 at 10:00 a.m. Eastern Time.
• · Conference call will include third quarter 2026 guidance.
• · Replay available for 90 days.
• · Tower Semiconductor owns facilities in Israel (200mm), U.S. (two 200mm), Japan (200mm and 300mm via 51% stake in TPSCo), and shares a 300mm facility in Italy with STMicroelectronics.

07-07-2026

Regal Partners Funds Management Pty Ltd and Regal Partners Ltd filed an amended Schedule 13G with the SEC on July 7, 2026, disclosing beneficial ownership of 45,215,626 ordinary shares of Opthea Ltd, representing 3.31% of the outstanding shares. The filing indicates no change in ownership from the prior period, with the same share count and percentage reported as of June 30, 2026.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b), indicating passive investment intent.
• · No American Depositary Shares were held; all 45,215,626 shares are ordinary shares.
• · The beneficial ownership percentage remained unchanged at 3.31% as of June 30, 2026.
• · Both Regal Partners Funds Management Pty Ltd and Regal Partners Limited reported identical share counts and percentages.

07-07-2026

Korea Electric Power Corporation (KEPCO) announced the appointment of Mr. Choi, Hoe-Yong as a non-standing director, effective July 7, 2026, replacing former director Mr. Kang, Hoon. Mr. Choi, a certified tax accountant, will serve a two-year term ending July 6, 2028. The filing contains no financial results or operational metrics.

• · Mr. Choi, Hoe-Yong was appointed by the Minister of the Ministry of Finance and Economy.
• · His term runs from July 7, 2026 to July 6, 2028.
• · He is a Representative Certified Tax Accountant at Hangil Tax & Accounting Office.
• · Previous role: Policy Advisory Committee Member, Presidential Committee on Autonomy and Decentralization.

07-07-2026

Artificial Intelligence Technology Solutions Inc. (AITX) filed an 8-K on July 7, 2026, announcing a press release titled 'AITX Combines Autonomous Mobility with Agentic AI for Physical Security.' The filing is furnished under Item 8.01 and includes the press release as Exhibit 99.1. No financial metrics or period-over-period comparisons were provided in this filing.

• · The press release is attached as Exhibit 99.1 and is furnished, not filed, under the Exchange Act.
• · The filing is dated July 7, 2026, and the press release was issued on the same date.
• · No financial data, revenue figures, or performance metrics were disclosed in this 8-K.

07-07-2026

Mitsubishi UFJ Financial Group, Inc. (MUFG) filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2026, with the U.S. SEC on July 6, 2026. The report includes audited consolidated financial statements prepared under U.S. GAAP. No specific financial figures or performance metrics were disclosed in this filing.

• · Annual Report filed on July 6, 2026, for fiscal year ended March 31, 2026.
• · Financial statements prepared under U.S. GAAP.
• · Report available on MUFG's website and free hard copies upon request.

07-07-2026

Alterity Therapeutics Ltd announced that FDA meeting minutes confirm a registrational path for its drug candidate ATH434. This regulatory milestone provides a clear pathway toward potential approval, but the company remains a development-stage enterprise with no approved products or revenue.

• · The company is a development-stage enterprise with no approved products or revenue.
• · The FDA meeting minutes confirm a registrational path for ATH434.

07-07-2026

Liquidity Services, Inc. announced the retirement of Chief Human Resources Officer Novelette Murray, effective July 6, 2026, and the appointment of Karen Fascenda as her successor on the same date. The change was disclosed in a press release furnished as an exhibit to the Form 8-K.

• · The press release is furnished as Exhibit 99.1 and incorporated by reference.
• · The effective date of both the retirement and appointment is July 6, 2026.

07-07-2026

Shell plc disclosed that its PDMRs, including CEO Wael Sawan, acquired dividend shares on July 2, 2026 following the Q1 2026 interim dividend paid June 29, 2026. The transactions were routine automatic reinvestments, with no market-based buys or sales, and no period-over-period comparisons to report.

• · Dividend shares were acquired on July 2, 2026, at varying prices (EUR 33.9265 per ordinary share, GBP 28.87677 per ordinary share, USD 78.03 per ADS).
• · Transactions took place on the Amsterdam and London exchanges.
• · CEO Wael Sawan received the largest block: 3,131.40275 ordinary shares (EUR) and 2,504.94524 ordinary shares (GBP).
• · Sinead Gorman received 3,325.58192 ordinary shares (GBP).

07-07-2026

Highlander Silver Corp. filed a Form 6-K with the SEC on July 7, 2026, attaching a press release dated the same day. The filing is a routine foreign issuer report under Rule 13a-16 or 15d-16, with no financial results or material operational updates disclosed in the filing itself.

• · The filing is a Form 6-K for the month of July 2026.
• · Commission file number: 001-43170.
• · The registrant files annual reports under Form 40-F.
• · The press release (Exhibit 99.1) is dated July 7, 2026, but its content is not included in this filing.

07-07-2026

Titan Mining Corporation filed a Form 6-K with the SEC on July 7, 2026, submitting a press release dated the same day. The filing is a routine foreign issuer report under Rule 13a-16, with no financial results or material operational updates disclosed in the cover filing itself.

• · The filing is a Form 6-K for the month of July 2026.
• · Commission File Number: 001-42955.
• · The registrant files annual reports under Form 40-F.
• · Principal executive office address: 408 Sylvia Lake Rd, Gouverneur, New York, NY 13642.

07-07-2026

Vertex Pharmaceuticals announced the acquisition of Crinetics Pharmaceuticals for $85 per share in cash, totaling approximately $10 billion ($8.8 billion net of cash). The deal adds potential best-in-class endocrinology assets including PALSONIFY (approved once-daily oral for acromegaly, launched October 2025 with strong early uptake) and atumelnant (Phase 3 for congenital adrenal hyperplasia). Vertex expects the acquisition to accelerate revenue growth and support sustained double-digit growth, with the transaction becoming accretive to non-GAAP operating income in 2029. However, the deal carries integration risks, requires regulatory and stockholder approvals, and the pipeline assets remain subject to clinical and commercial uncertainties.

• · PALSONIFY is FDA and EMA approved; U.S. launch occurred in October 2025.
• · Atumelnant is in Phase 3 for adults and Phase 2/3 for pediatric CAH, and Phase 2 for ACTH-dependent Cushing's syndrome.
• · Crinetics has IP protection into the 2040s.
• · Crinetics was founded in 2008 and is headquartered in San Diego, CA.
• · Only ~40-50% of acromegaly patients achieve durable remission with surgery.
• · Only 18% of patients remain on injectable SRLs at ~3 years, indicating high discontinuation.
• · PALSONIFY is indicated for both treatment-naïve and switch patients.
• · Vertex expects the transaction to be accretive to non-GAAP operating income in 2029.
• · The acquisition is supported by fully committed bridge financing.

07-07-2026

City Center Advisors, LLC filed its quarterly 13F-HR for the period ending June 30, 2026, reporting a portfolio value of approximately $123.5 million across 170 holdings. The filing shows a diversified mix of equities and ETFs, with top positions in SPDR S&P 500 Growth ETF ($8.8M), SPDR S&P 500 Value ETF ($7.9M), and PIMCO Enhanced Short Maturity Active ETF ($4.8M). While the portfolio is heavily weighted toward U.S. large-cap ETFs and fixed-income products, it also includes notable holdings in technology giants like Apple ($2.1M) and NVIDIA ($1.5M), as well as smaller positions in speculative names such as Harmony Biosciences and Credo Technology Group.

• · The portfolio includes 170 holdings with a total value of $123,491,164.
• · Top holdings by market value are SPDR S&P 500 Growth ETF ($8,767,250), SPDR S&P 500 Value ETF ($7,934,791), and PIMCO Enhanced Short Maturity Active ETF ($4,795,997).
• · Notable individual stock positions include Apple Inc. ($2,059,441), NVIDIA Corporation ($1,494,493), Broadcom Inc. ($1,049,140), and Eli Lilly & Co. ($1,019,655).
• · The filing was signed by Aryn Sands as Agent for City Center Advisors, LLC.
• · The portfolio is heavily weighted toward ETFs, particularly those tracking U.S. large-cap indices and fixed-income strategies.

07-07-2026

Spring Valley Acquisition Corp. III shareholders approved the business combination with General Fusion Inc., a fusion energy company, on July 6, 2026. The combined company, to be renamed General Fusion Group Ltd., is expected to begin trading on Nasdaq under ticker 'GFUZ' on or about July 10, 2026, subject to regulatory approvals. This milestone positions General Fusion as the first publicly traded pure-play fusion company, though the transaction remains subject to closing conditions and regulatory approvals.

• · General Fusion was established in 2002 and is headquartered in Vancouver, Canada.
• · LM26 is the first MTF demonstration machine built at commercially relevant scale, operating at 50% commercial-scale diameter.
• · LM26 aims to achieve plasma heating to 1 keV (10 million degrees Celsius), then 10 keV (100 million degrees Celsius), and ultimately the Lawson criterion for net fusion energy.
• · Spring Valley vehicles have raised $920 million in four IPOs over the past 5 years.
• · Spring Valley I completed a business combination with NuScale Power Corporation (small modular reactor technology).
• · Spring Valley II completed a business combination with Eagle Nuclear Energy Corp. (uranium deposit rights).

07-07-2026

MOULTON WEALTH MANAGEMENT, INC filed its quarterly 13F-HR for the period ending June 30, 2026, reporting 66 equity holdings with a total market value of approximately $152.1 million. The portfolio is heavily weighted toward fixed-income and floating-rate ETFs, with the top positions including SPDR Series Trust ST STR P500ETF ($18.3M), iShares TR TRS FLT RT BD ($13.7M), and WisdomTree TR FLOATNG RAT TREA ($13.5M), reflecting a defensive, income-oriented strategy. No period-over-period comparisons are available in this initial filing, so performance trends cannot be assessed.

• · The portfolio includes a significant allocation to floating-rate and short-term bond ETFs, suggesting a focus on interest rate risk management.
• · Gold and precious metals exposure is notable, with holdings in SPDR Gold TR ($2.0M), iShares Gold TR ($0.5M), iShares Silver TR ($1.2M), and ProShares ULTRASHORT GOLD ($4.3M).
• · The largest single equity position is SPDR Series Trust ST STR P500ETF at $18.3M, representing about 12% of total portfolio value.
• · No individual stock holdings exceed $2M; the largest single stock is Exxon Mobil Corp at $1.86M.
• · The filing indicates all shares are held with sole voting and dispositive power.